Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pope

Showing results (371-380 of 381) with videos related to

Pageof 39
Sort By:
Cancer Discovery|June 17, 2026
The Landscape of Prostate Tumour MethylationJaron Arbet, Takafumi N Yamaguchi, Yu-Jia Shiah, et al.
European Urology|June 6, 2022
Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group StudyDaniel Burns, Ezequiel Anokian, Edward J Saunders, et al.
Cancer Discovery|July 23, 2014
Rare mutations in RINT1 predispose carriers to breast and Lynch syndrome-spectrum cancersDaniel J Park, Kayoko Tao, Florence Le Calvez-Kelm, et al.
Cell Genomics|March 1, 2024
Genomic evolution shapes prostate cancer disease typeDan J Woodcock, Atef Sahli, Ruxandra Teslo, et al.
Medrxiv : the Preprint Server for Health Sciences|March 13, 2023
A tumor focused approach to resolving the etiology of DNA mismatch repair deficient tumors classified as suspected Lynch syndromeRomy Walker, Khalid Mahmood, Jihoon E Joo, et al.
Journal of Translational Medicine|April 26, 2023
A tumor focused approach to resolving the etiology of DNA mismatch repair deficient tumors classified as suspected Lynch syndromeRomy Walker, Khalid Mahmood, Jihoon E Joo, et al.
Nature Communications|June 6, 2022
Identifying colorectal cancer caused by biallelic MUTYH pathogenic variants using tumor mutational signaturesPeter Georgeson, Tabitha A Harrison, Bernard J Pope, et al.
Medrxiv : the Preprint Server for Health Sciences|April 24, 2023
Genotoxic colibactin mutational signature in colorectal cancer is associated with clinicopathological features, specific genomic alterations and better survivalPeter Georgeson, Robert S Steinfelder, Tabitha A Harrison, et al.
Nature Communications|July 14, 2018
Author Correction: Prioritizing multiple therapeutic targets in parallel using automated DNA-encoded library screeningCarl A Machutta, Christopher S Kollmann, Kenneth E Lind, et al.
Nature Communications|July 18, 2017
Prioritizing multiple therapeutic targets in parallel using automated DNA-encoded library screeningCarl A Machutta, Christopher S Kollmann, Kenneth E Lind, et al.
Pageof 39

Showing results (371-380 of 381) with videos related to

Sort By:
Pageof 39
Cancer Discovery|June 17, 2026
The Landscape of Prostate Tumour MethylationJaron Arbet, Takafumi N Yamaguchi, Yu-Jia Shiah, et al.
European Urology|June 6, 2022
Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group StudyDaniel Burns, Ezequiel Anokian, Edward J Saunders, et al.
Cancer Discovery|July 23, 2014
Rare mutations in RINT1 predispose carriers to breast and Lynch syndrome-spectrum cancersDaniel J Park, Kayoko Tao, Florence Le Calvez-Kelm, et al.
Cell Genomics|March 1, 2024
Genomic evolution shapes prostate cancer disease typeDan J Woodcock, Atef Sahli, Ruxandra Teslo, et al.
Medrxiv : the Preprint Server for Health Sciences|March 13, 2023
A tumor focused approach to resolving the etiology of DNA mismatch repair deficient tumors classified as suspected Lynch syndromeRomy Walker, Khalid Mahmood, Jihoon E Joo, et al.
Journal of Translational Medicine|April 26, 2023
A tumor focused approach to resolving the etiology of DNA mismatch repair deficient tumors classified as suspected Lynch syndromeRomy Walker, Khalid Mahmood, Jihoon E Joo, et al.
Nature Communications|June 6, 2022
Identifying colorectal cancer caused by biallelic MUTYH pathogenic variants using tumor mutational signaturesPeter Georgeson, Tabitha A Harrison, Bernard J Pope, et al.
Medrxiv : the Preprint Server for Health Sciences|April 24, 2023
Genotoxic colibactin mutational signature in colorectal cancer is associated with clinicopathological features, specific genomic alterations and better survivalPeter Georgeson, Robert S Steinfelder, Tabitha A Harrison, et al.
Nature Communications|July 14, 2018
Author Correction: Prioritizing multiple therapeutic targets in parallel using automated DNA-encoded library screeningCarl A Machutta, Christopher S Kollmann, Kenneth E Lind, et al.
Nature Communications|July 18, 2017
Prioritizing multiple therapeutic targets in parallel using automated DNA-encoded library screeningCarl A Machutta, Christopher S Kollmann, Kenneth E Lind, et al.
Pageof 39